PMID: 2485906Nov 1, 1989Paper

Comparative in vitro study of RGH-2981, a new peripheral blood flow enhancer on animal and pathological human arteries

Polish Journal of Pharmacology and Pharmacy
Z SzombathelyiA Till

Abstract

The aim of the present investigation was to compare the activity of RGH-2981 and two reference compounds, verapamil and LY 53857 on isolated, normal animal and pathological human arteries. The majority of the latter displayed vasoconstriction against 5-HT, or KCl, what evidences that despite serious vascular damage they did not develop a total functional failure. RGH-2981 showed a moderate serotonin and Ca++ antagonistic activity in both normal rabbit and pathological human arteries.

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.